Company · CIK 1868279

# ArriVent BioPharma, Inc.

| CIK | [1868279](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001868279) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | PA |
| Listed | AVBP (Nasdaq) |
| First annual or quarterly report | 2024-03-28 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-284661 | Shelf Effective | 2025-02-03 | 2026-05-11 | 4 |
| 333-276397 | IPO Final prospectus | 2024-01-05 | 2024-01-26 | 5 |

## Filings

 10

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-05-11 | [424B5](https://www.sec.gov/Archives/edgar/data/1868279/000110465926058700/0001104659-26-058700-index.htm) Shelf takedown | 333-284661 | 0001104659-26-058700 |
| 2025-07-02 | [424B5](https://www.sec.gov/Archives/edgar/data/1868279/000110465925065391/0001104659-25-065391-index.htm) Shelf takedown | 333-284661 | 0001104659-25-065391 |
| 2025-07-01 | [424B5](https://www.sec.gov/Archives/edgar/data/1868279/000110465925064736/0001104659-25-064736-index.htm) Shelf takedown | 333-284661 | 0001104659-25-064736 |
| 2025-02-03 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1868279/000110465925008356/0001104659-25-008356-index.htm) Shelf registered | 333-284661 | 0001104659-25-008356 |
| 2024-01-26 | [424B4](https://www.sec.gov/Archives/edgar/data/1868279/000110465924007261/0001104659-24-007261-index.htm) Final prospectus | 333-276397 | 0001104659-24-007261 |
| 2024-01-25 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1868279/999999999524000212/9999999995-24-000212-index.htm) Declared effective | 333-276397 | 9999999995-24-000212 |
| 2024-01-23 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1868279/000110465924005933/0001104659-24-005933-index.htm) Amendment | 333-276397 | 0001104659-24-005933 |
| 2024-01-22 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1868279/000110465924005364/0001104659-24-005364-index.htm) Amendment | 333-276397 | 0001104659-24-005364 |
| 2024-01-05 | [S-1](https://www.sec.gov/Archives/edgar/data/1868279/000110465924001804/0001104659-24-001804-index.htm) Registration filed | 333-276397 | 0001104659-24-001804 |
| 2023-08-25 | [DRS](https://www.sec.gov/Archives/edgar/data/1868279/000110465923095379/0001104659-23-095379-index.htm) Draft made public | 377-06842 | 0001104659-23-095379 |

[All filings of this company](https://equitycapital.markets/filings?cik=1868279) · [CSV](https://equitycapital.markets/filings.csv?cik=1868279)

---
Source page: https://equitycapital.markets/company/1868279 · Data: U.S. SEC EDGAR · CC BY 4.0